-, METHYLPREDNISOLONE, FLUDARABINE, -, MESNA, -, Tecartus 0.4 – 2 × 108 cells dispersion for infusion, CYCLOPHOSPHAMIDE, DEXAMETHASONE clinical trials

A Phase 2, Open-Label, Multicenter, Basket Study Evaluating the Safety and Efficacy of Brexucabtagene Autoleucel in Adults with Rare B-cell Malignancies (ZUMA-25) – Substudy D - Relapsed/Refractory Hairy Cell Leukemia (HCL)

This study looks at a new cell therapy called Tecartus for adults with a rare blood cancer called hairy cell leukaemia. It aims to see how well it works and if it's safe for people whose cancer has come back or hasn't responded to previous treatments.